Found: 7
Select item for more details and to access through your institution.
A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28064-7
- By:
- Publication type:
- Article
Structural specificities of cell surface β-glucan polysaccharides determine commensal yeast mediated immuno-modulatory activities.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23929-9
- By:
- Publication type:
- Article
Association of gut microbial dysbiosis with disease severity, response to therapy and disease outcomes in Indian patients with COVID-19.
- Published in:
- Gut Pathogens, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13099-023-00546-z
- By:
- Publication type:
- Article
Microbiome Metabolome Integration Platform (MMIP): a web-based platform for microbiome and metabolome data integration and feature identification.
- Published in:
- Briefings in Bioinformatics, 2023, v. 24, n. 6, p. 1, doi. 10.1093/bib/bbad325
- By:
- Publication type:
- Article
Butyrate limits inflammatory macrophage niche in NASH.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 5, p. 1, doi. 10.1038/s41419-023-05853-6
- By:
- Publication type:
- Article
Interplay of Various Evolutionary Modes in Genome Diversification and Adaptive Evolution of the Family Sulfolobaceae.
- Published in:
- Frontiers in Microbiology, 2021, v. 12, p. 1, doi. 10.3389/fmicb.2021.639995
- By:
- Publication type:
- Article
Nature and dimensions of the systemic hyper-inflammation and its attenuation by convalescent plasma in severe COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article